Cetuximab for resectable colorectal liver metastasis: new EPOC trial--author's reply

Lancet Oncol. 2014 Jul;15(8):e306. doi: 10.1016/S1470-2045(14)70241-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Colorectal Neoplasms / drug therapy*
  • Female
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / secondary*
  • Male

Substances

  • Antibodies, Monoclonal, Humanized